Felizia K Voss

Title: Felizia K Voss: Innovator in Protein Complexes

Introduction

Felizia K Voss is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of molecular medicine, particularly in the study of LRRC8 proteins and their complexes. Her work focuses on identifying channel modulators that interact with these proteins, which are crucial for various physiological processes.

Latest Patents

Felizia K Voss holds a patent for her invention titled "LRRC8 proteins and protein complexes and methods for identification of channel modulators." This invention relates to a method for identifying channel modulators, such as agonists or antagonists, that interact with one or more of the LRRC8 proteins (LRRC8A, LRRC8B, LRRC8C, LRRC8D, and/or LRRC8E). The patent also covers isolated heteromeric protein complexes comprising these proteins, which can be utilized in methods for identifying VRAC (VSOAC) modulators. This innovative work has the potential to advance therapeutic strategies in various medical fields.

Career Highlights

Throughout her career, Felizia K Voss has worked with esteemed institutions, including the Max Delbrück Center for Molecular Medicine and the Forschungsverbund Berlin E.V. Her research has significantly impacted the understanding of protein interactions and their implications in health and disease.

Collaborations

Felizia has collaborated with notable scientists such as Thomas Jentsch and Tobias Stauber. These collaborations have enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Felizia K Voss is a trailblazer in the study of LRRC8 proteins and their complexes. Her innovative patent and collaborative efforts highlight her commitment to advancing molecular medicine. Her work continues to inspire future research in the identification of channel modulators.